Houlihan Lokey, Inc. logo HLI - Houlihan Lokey, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 5
SELL 1
STRONG
SELL
0
| PRICE TARGET: $163.60 DETAILS
HIGH: $187.00
LOW: $145.00
MEDIAN: $161.00
CONSENSUS: $163.60
UPSIDE: 19.97%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Overvalued Moderate
Trading 30.2% above fair value
Current Price $136.37
Bear Case $73.33 46.2% downside ($73.33 - $136.37) / $136.37 = -46.2% ROTCE 20.0% → 2.85x TBV
Fair Value $104.76 23.2% downside ($104.76 - $136.37) / $136.37 = -23.2% ROTCE 25.0% → 3.74x TBV
Bull Case $136.19 0.1% downside ($136.19 - $136.37) / $136.37 = -0.1% ROTCE 30.0% → 4.00x TBV

Adjust Assumptions

57.3%
9.6%

Key Value Driver

ROTCE (57.3%) vs. cost of equity (9.6%)

Implied Market Multiple 12.84x

Plain-Language Summary

With ROTCE of 57.3% vs. 9.6% cost of equity, fair P/TBV is 3.74x on $10.62 tangible book, implying $104.76 per share. DDM cross-check: $82.04.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (15 analysts) $163.60
Analyst Range $145.00 – $187.00
Divergence from AlphaVal 36%

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $163.60 (from 15 analysts). Our estimate is 36% below the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly